2013-11-12T11:32:22-06:00 2012-12-31 521855942 TATE AND TRYON 2021 L STREET NW SUITE 400 WASHINGTON DC 20036 990 2012-01-01 521906152 PARENTERAL DRUG ASSOCIATION INC PARE 3016565900 4350 EAST WEST HIGHWAY BETHESDA MD 20814 CRAIG ELLIOTT 3016565900 2013-11-12 1 ELIZABETH W HELLER P00397829 2022932200 2012 2016-02-25 16:41:14Z RICHARD JOHNSON 4350 EAST WEST HIGHWAY BETHESDA MD 20814 13333368 0 X WWW.PDA.ORG X 1994 DC TO BE THE FOREMOST GLOBAL PROVIDER OF SCIENCE, TECHNOLOGY AND REGULATORY INFORMATION AND EDUCATION FOR THE PHARMACEUTICAL AND BIOPHARMACEUTICAL COMMUNITY. 17 16 39 1032 373404 -500 101190 123223 9503197 11781425 -1025271 59006 958345 1010781 9537461 12974435 0 0 0 0 3627239 4506387 0 0 0 5878761 7000038 9506000 11506425 31461 1468010 7461630 8480557 3922110 3538799 3539520 4941758 X TO DEVELOP SCIENTIFICALLY SOUND, PRACTICAL TECHNICAL INFORMATION AND RESOURCES TO ADVANCE SCIENCE AND REGULATION FOR THE PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY THROUGH THE EXPERTISE OF OUR GLOBAL MEMBERSHIP. 0 0 PROGRAMS & MEETINGS-EDUCATE MEMBERS AND NON-MEMBERS BY TEACHING DEVELOPMENTS IN MANUFACTURING AND QUALITY CONTROL FOR PRIMARY STERILE PRODUCT DEVELOPMENT. TRAINING & RESEARCH INSTITUTE (TRI)EDUCATIONAL COURSES - TECHNICAL TRAINING FOR SCIENTISTS IN THE PHARMACEUTICAL AREAS OF MANUFACTURING, DEVELOPMENT AND QUALITY CONTROL.TRAINING- TRAIN MEMBERS AND NON-MEMBERS TO BASIC MANUFACTURING TECHNIQUES CENTERED AROUND GMP GUIDELINES. MEMBERSHIP & CHAPTER SERVICES-PROVIDE THE LATEST GUIDELINES FOCUSING ON TECHNOLOGY INFORMATION ON MANUFACTURING, TECHNICAL REPORTS, AND QUALITY CONTROL. PUBLICATION SALES- PROVIDE THE LATEST SCIENCE, TECHNOLOGY AND REGULATORY INFORMATIONSALES, EXHIBIT & SPONSORSHIP, ADVERTISING- PROVIDE THE LATEST SCIENCE, TECHNOLOGY AND REGULATORY INFORMATION 0 1 0 1 0 0 0 0 0 1 0 0 0 1 1 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 1 84 0 1 39 1 1 1 0 0 0 1 1 0 X 17 16 0 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 MD X CRAIG ELLIOTT CFO 3016565900 4350 EAST WEST HIGHWAY BETHESDA MD 20814 URSULA BUSSE 1.50 1.00 X 0 0 0 JETTE CHRISTENSEN 1.50 1.00 X 0 0 0 ZENA KAUFMAN 1.50 1.00 X 0 0 0 JOHN FINKBOHNER 1.50 1.00 X 0 0 0 GABRIELE GORI 1.50 1.00 X 0 0 0 JUNKO SASAKI 1.50 1.00 X 0 0 0 SUE SCHNIEPP 1.50 1.00 X 0 0 0 MICHAEL SADOWSKI 1.50 1.00 X 0 0 0 LISA SKEENS 1.50 1.00 X 0 0 0 CHRISTOPHER SMALLEY 1.50 1.00 X 0 0 0 MARTIN VANTRIESTE 1.50 1.00 X 0 0 0 GLENN WRIGHT 1.50 1.00 X 0 0 0 ANDERS VINTHER PHD 1.50 1.00 X X 0 0 0 HAROLD BASEMAN 1.50 1.00 X X 32000 0 0 STEVEN MENDIVIL 1.50 1.00 X X 0 0 0 REBECCA DEVINE PHD 1.50 1.00 X X 0 0 0 MAIK W JORNITZ 1.50 1.00 X X 3000 0 0 RICHARD JOHNSON 37.50 1.00 X 358153 0 21140 CRAIG ELLIOTT 37.50 X 272617 0 13161 RICHARD LEVY 37.50 X 287256 0 22027 WANDA NEAL 37.50 X 249546 0 14173 ADRIENNE FIERRO 37.50 X 157975 0 10691 ROBERT L DANA 37.50 X 169649 0 5208 DAVID HALL 37.50 X 267252 0 0 WALTER L MORRIS 37.50 X 104181 0 20198 FENG CHEN 37.50 X 105197 0 10702 2006826 0 117300 9 0 1 0 DHI PUBLISHING LLC 1710 E HINTZ RD ARLINGTON HEIGHTS IL 60004 BOOK SALES 269847 1 123223 123223 123223 MEETINGS, EXHIBITS & C 541900 6205858 6205858 EDUCATION 541900 3295142 3295142 MEMBERSHIP DUES 900099 2280425 2280425 11781425 59006 59006 96816 96816 22308 0 22308 22308 22308 836177 358933 477244 477244 ADVERTISING 541800 373404 373404 OTHER REVENUE 900099 41009 41009 414413 12974435 12258669 373404 219139 1897497 1670141 319165 408646 210938 27251 35175 1037087 594830 1129939 82954 724891 503014 2170258 526626 39958 FOREIGN EXCHANGE ADJUST 68122 MISCELLANEOUS EXPENSE 59933 11506425 1468244 2595456 3047631 3690077 33311 136562 124869 110559 228977 274368 4537635 3071026 1710064 1466609 848534 206926 7461630 8480557 1006140 989979 2667875 2290699 248095 258121 3922110 3538799 X 3539520 4941758 3539520 4941758 7461630 8480557 1468010 97082 -162854 0 X X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 1185949 733364 452585 1751123 1182667 568456 1600563 1154995 445568 1466609 DEFERRED RENT 252201 DUE TO CHAPTERS 5920 258121 X 13430450 97082 97082 13333368 -358933 -358933 12974435 11865358 358933 358933 11506425 0 11506425 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY INCOME TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE ANY UNCERTAIN INCOME TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. THE ORGANIZATION'S INCOME TAX RETURNS ARE GENERALLY SUBJECT TO EXAMINATION BY TAXING AUTHORITIES FOR THREE YEARS AFTER THEY ARE FILED. PART XI, LINE 4B - OTHER ADJUSTMENTS: COGS TO REVENUE PART VIII -358,933. PART XII, LINE 2D - OTHER ADJUSTMENTS: COGS TO REVENUE PART VIII 358,933. EAST ASIA AND THE PACIFIC - 0 0 PROGRAM SERVICES PHARMACEUTICAL QUALITY SYSTEMS ICH-Q10 & WORKSHOP SPONSORSHIP 115926 0 0 0 0 0 0 115926 0 115926 0 0 0 0 0 0 X 1 1 X X X X 0 0 0 RICHARD JOHNSON 272102 0 78810 0 7241 0 4661 0 22592 0 385406 0 0 0 CRAIG ELLIOTT 220685 0 46675 0 5257 0 6473 0 9507 0 288597 0 0 0 RICHARD LEVY 232558 0 49480 0 5218 0 8568 0 16778 0 312602 0 0 0 WANDA NEAL 189378 0 39600 0 20568 0 7484 0 12164 0 269194 0 0 0 ADRIENNE FIERRO 131526 0 20030 0 6419 0 4003 0 9823 0 171801 0 0 0 ROBERT L DANA 169374 0 0 0 275 0 255 0 7564 0 177468 0 0 0 DAVID HALL 267252 0 0 0 0 0 0 0 0 0 267252 0 0 0 PART I, LINE 1A PDA PAYS 90% OF THE COST FOR USE OF A HEALTH CLUB (GYM) FOR ALL OF ITS EMPLOYEES. SUPPLEMENTAL INFORMATION PART III PDA UTILIZES THE SERVICES OF A PROFESSIONAL EMPLOYER ORGANIZATION (PEO), WHICH ACTS AS CO-EMPLOYER FOR PDA EMPLOYEES REPORTED IN THIS FORM 990. X LAB SUPPLIES 9 123223 FAIR MARKET VALUE 0 0 0 FORM 990, PART VI, SECTION A, LINE 6 THE ASSOCIATION HAS THE FOLLOWING CLASSES OF MEMBERS: --INDIVIDUAL MEMBERS --ASSOCIATE MEMBERS --HONORARY MEMBERS --EMERITUS MEMBERS FORM 990, PART VI, SECTION A, LINE 7A PDA'S GLOBAL MEMBERSHIP IS ELIGIBLE TO VOTE TO ELECT PDA'S BOARD OF DIRECTORS. THE PROCESS IS AS FOLLOWS: A NOMINATING COMMITTEE, CONSISTING OF THE CHAIRMAN, CHAIRMAN-ELECT, AND IMMEDIATE PAST CHAIRMAN, SUBMITS TO THE BOARD OF DIRECTORS A SLATE WITH (2) NOMINATED CANDIDATES FOR EACH OFFICER POSITION AND (2) NOMINATED CANDIDATES FOR EACH ELECTED DIRECTOR POSITION. THE BOARD OF DIRECTORS, THEN VOTES TO SELECT 1 CANDIDATE FOR EACH OPEN POSITION TO SEND TO THE FULL MEMBERSHIP FOR VOTING. AN ELECTRONIC BALLOT CONTAINING THE NAMES OF ALL CANDIDATES FOR ELECTION, WITH PROVISION FOR A "WRITE-IN" CANDIDATE FOR EACH POSITION TO BE FILLED, IS THEN PROVIDED TO EACH ASSOCIATION MEMBER ENTITLED TO VOTE. AN ELECTED OFFICER MAY BE REMOVED FROM OFFICE BY VOTE OF AT LEAST TWELVE (12) DIRECTORS OR BY TWO-THIRDS (2/3) VOTE OF ALL INDIVIDUAL MEMBERS OF THE ASSOCIATION. LIKEWISE, AN ELECTED DIRECTOR MAY BE REMOVED FROM OFFICE BY VOTE OF AT LEAST TWELVE (12) DIRECTORS OR BY TWO-THIRDS (2/3) VOTE OF ALL INDIVIDUAL MEMBERS OF THE ASSOCIATION. FORM 990, PART VI, SECTION A, LINE 7B BYLAWS AMENDMENT PROCESS: EACH PROPOSED AMENDMENT OF PDA'S BYLAWS, APPROVED BY VOTE OF AT LEAST TWELVE (12) DIRECTORS, SHALL BE SUBMITTED WITH A BALLOT TO ALL PDA MEMBERS ENTITLED TO VOTE. A PROPOSED BYLAWS AMENDMENT SHALL BECOME EFFECTIVE UPON RECEIVING A TWO-THIRDS (2/3) "YES" VOTE OF THE MEMBER BALLOTS RECEIVED. FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 IS REVIEWED BY THE PRESIDENT AND EXECUTIVE COMMITTEE MEMBERS. THE FORM 990, IN PDF FILE FORMAT, IS THEN PROVIDED TO THE FULL GOVERNING BODY (BOARD OF DIRECTORS) PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C FROM PDA'S CONFLICT OF INTEREST POLICY: 1. DUTY TO DISCLOSE IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. 2. DETERMINING WHETHER A CONFLICT OF INTEREST EXISTS AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE SHALL LEAVE THE GOVERNING BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. 3. PROCEDURES FOR ADDRESSING THE CONFLICT OF INTEREST A. AN INTERESTED PERSON MAY MAKE A PRESENTATION AT THE GOVERNING BOARD OR COMMITTEE MEETING, BUT AFTER THE PRESENTATION, HE/SHE SHALL LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT INVOLVING THE POSSIBLE CONFLICT OF INTEREST. B. THE CHAIRPERSON OF THE GOVERNING BOARD OR COMMITTEE SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. C. AFTER EXERCISING DUE DILIGENCE, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE WHETHER PDA CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. D. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE UNDER CIRCUMSTANCES NOT PRODUCING A CONFLICT OF INTEREST, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN PDA'S BEST INTEREST, FOR ITS OWN BENEFIT, AND WHETHER IT IS FAIR AND REASONABLE. IN CONFORMITY WITH THE ABOVE DETERMINATION IT SHALL MAKE ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT. 4. VIOLATIONS OF THE CONFLICTS OF INTEREST POLICY A. IF THE GOVERNING BOARD OR COMMITTEE HAS REASONABLE CAUSE TO BELIEVE A MEMBER HAS FAILED TO DISCLOSE ACTUAL OR POSSIBLE CONFLICTS OF INTEREST, IT SHALL INFORM THE MEMBER OF THE BASIS FOR SUCH BELIEF AND AFFORD THE MEMBER AN OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE. B. IF, AFTER HEARING THE MEMBER'S RESPONSE AND AFTER MAKING FURTHER INVESTIGATION AS WARRANTED BY THE CIRCUMSTANCES, THE GOVERNING BOARD OR COMMITTEE DETERMINES THE MEMBER HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT SHALL TAKE APPROPRIATE DISCIPLINARY AND CORRECTIVE ACTION. FORM 990, PART VI, SECTION B, LINE 15 PDA'S COMPENSATION COMMITTEE RECOMMENDS COMPENSATION AMOUNTS TO THE BOARD OF DIRECTORS' EXECUTIVE COMMITTEE, WHICH THEN REVIEWS AND APPROVES EXECUTIVE COMPENSATION. BOTH COMMITTEES USE INDUSTRY BENCHMARK DATA TO SET COMPENSATION RANGES. FORM 990, PART VI, SECTION C, LINE 19 POLICIES AND PROCEDURES ARE MAINTAINED AND AVAILABLE TO THE ASSOCIATION'S GOVERNING BODIES AND MEMBERS. FORM 990, PART XII, LINE 2C THE AUDIT REVIEW PROCESS HAS REMAINED UNCHANGED FROM THE PRIOR YEAR. FOUNDATION FOR PHARMACEUTICAL EDUCATION TRAINING AND RESEARCH 4350 EAST WEST HWY STE 200 BETHESDA MD 20814 522075244 SUPPORT EDUCATION, TRAINING AND RESEARCH IN THE PHARMACEUTICAL SCIENCES DC 501(C)(3) 509(A)(3) TYPE 1 1 PDA EUROPE GEMEINNUTZIGE GMBH ADALBERTSTRASSE 9 GLIENICKE/NORDBAHN GM 16548 SHARES PDA MISSION AS STATED ON PAGE 1 OF THIS FORM 990 GM NONPROFIT GERMAN COM 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 PDA EUROPE GEMEINNUTZIGE GMBH D -647738 NET DUE TO/FROM ACTIVITY FDTN FOR PHARMACEUTICAL ED TRAINING & RESEARCH D 6074 NET DUE TO/FROM ACTIVITY PDA EUROPE GEMEINNUTZIGE GMBH Q 590905 PAYMENT RECEIVED